Visualizing Cancer Cell Chemotaxis and Invasion in 2D and 3D

Author(s):  
Olivia Susanto ◽  
Andrew J. Muinonen-Martin ◽  
Max Nobis ◽  
Robert H. Insall
2018 ◽  
Vol 72 (3) ◽  
pp. 148-154 ◽  
Author(s):  
Yinzhi Lin ◽  
Yue Chen ◽  
Tamami Ukaji ◽  
Shoshiro Okada ◽  
Kazuo Umezawa

2013 ◽  
Vol 12 (11) ◽  
pp. 3199-3209 ◽  
Author(s):  
Xiaofang Zhang ◽  
Fei Zhang ◽  
Lin Guo ◽  
Yanping Wang ◽  
Peng Zhang ◽  
...  

2020 ◽  
Vol 18 (6) ◽  
pp. 913-925
Author(s):  
Natalya Chernichenko ◽  
Tatiana Omelchenko ◽  
Sylvie Deborde ◽  
Richard L. Bakst ◽  
Shizhi He ◽  
...  

2004 ◽  
Vol 300 (1) ◽  
pp. 180-189 ◽  
Author(s):  
Shur-Jen Wang ◽  
Wajeeh Saadi ◽  
Francis Lin ◽  
Connie Minh-Canh Nguyen ◽  
Noo Li Jeon

2006 ◽  
Vol 8 (2) ◽  
pp. 109-118 ◽  
Author(s):  
Wajeeh Saadi ◽  
Shur-Jen Wang ◽  
Francis Lin ◽  
Noo Li Jeon

2017 ◽  
Vol Volume 11 ◽  
pp. 3273-3280 ◽  
Author(s):  
Miglė Paškevičiūtė ◽  
Vilma Petrikaitė

2020 ◽  
Vol 21 (9) ◽  
pp. 3203 ◽  
Author(s):  
Layla Mohammad Hadi ◽  
Elnaz Yaghini ◽  
Alexander J. MacRobert ◽  
Marilena Loizidou

In this study we explored the efficacy of combining low dose photodynamic therapy using a porphyrin photosensitiser and dactinomycin, a commonly used chemotherapeutic agent. The studies were carried out on compressed collagen 3D constructs of two human ovarian cancer cell lines (SKOV3 and HEY) versus their monolayer counterparts. An amphiphilc photosensitiser was employed, disulfonated tetraphenylporphine, which is not a substrate for ABC efflux transporters that can mediate drug resistance. The combination treatment was shown to be effective in both monolayer and 3D constructs of both cell lines, causing a significant and synergistic reduction in cell viability. Compared to dactinomycin alone or PDT alone, higher cell kill was found using 2D monolayer culture vs. 3D culture for the same doses. In 3D culture, the combination therapy resulted in 10 and 22 times higher cell kill in SKOV3 and HEY cells at the highest light dose compared to dactinomycin monotherapy, and 2.2 and 5.5 times higher cell kill than PDT alone. The combination of low dose PDT and dactinomycin appears to be a promising way to repurpose dactinomycin and widen its therapeutic applications.


Sign in / Sign up

Export Citation Format

Share Document